Literature DB >> 8847657

Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders.

M S Keshavan1, J Miewald, G Haas, J Sweeney, R Ganguli, C F Reynolds.   

Abstract

Deficits in slow-wave sleep (SWS), or delta sleep, are frequently seen in schizophrenia, but their relationship with schizophrenic symptomatology remains unclear. We examined the association between visually scored and automated measures of SWS and positive and negative symptoms in a series of unmedicated patients with schizophrenia and related psychotic disorders. Total and average automated delta wave counts were significantly inversely associated with negative symptoms overall, and the psychomotor poverty syndrome in particular. Total delta counts were also inversely related to the disorganization syndrome. No relation was seen between reality distortion or the Brief Psychiatric Rating Scale (BPRS) positive symptoms and SWS. These findings support the view that SWS deficits may be related to negative symptoms of schizophrenia and may perhaps be mediated by impaired functioning of frontothalamic neural circuits.

Entities:  

Mesh:

Year:  1995        PMID: 8847657     DOI: 10.1016/0022-3956(95)00023-x

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  18 in total

1.  Regulation of inhibitory synapses by presynaptic D₄ dopamine receptors in thalamus.

Authors:  Gubbi Govindaiah; Tongfei Wang; Martha U Gillette; Shane R Crandall; Charles L Cox
Journal:  J Neurophysiol       Date:  2010-09-08       Impact factor: 2.714

2.  Reduced frontal asymmetry of delta waves during all-night sleep in schizophrenia.

Authors:  Masanori Sekimoto; Masaaki Kato; Tsuyoshi Watanabe; Naofumi Kajimura; Kiyohisa Takahashi
Journal:  Schizophr Bull       Date:  2006-12-16       Impact factor: 9.306

3.  Interconnected parallel circuits between rat nucleus accumbens and thalamus revealed by retrograde transynaptic transport of pseudorabies virus.

Authors:  P O'Donnell; A Lavín; L W Enquist; A A Grace; J P Card
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

4.  Sex Differences in Subjective Sleep Quality Patterns in Schizophrenia.

Authors:  Michelle H Chen; Stephanie A Korenic; Emerson M Wickwire; S Andrea Wijtenburg; L Elliot Hong; Laura M Rowland
Journal:  Behav Sleep Med       Date:  2019-08-28       Impact factor: 2.964

5.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 6.  Sleep and mental disorders: A meta-analysis of polysomnographic research.

Authors:  Chiara Baglioni; Svetoslava Nanovska; Wolfram Regen; Kai Spiegelhalder; Bernd Feige; Christoph Nissen; Charles F Reynolds; Dieter Riemann
Journal:  Psychol Bull       Date:  2016-07-14       Impact factor: 17.737

Review 7.  Psychiatric disorders and sleep.

Authors:  Andrew D Krystal
Journal:  Neurol Clin       Date:  2012-11       Impact factor: 3.806

8.  State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effects.

Authors:  Robert W Gould; Michael T Nedelcovych; Xuewen Gong; Erica Tsai; Michael Bubser; Thomas M Bridges; Michael R Wood; Mark E Duggan; Nicholas J Brandon; John Dunlop; Michael W Wood; Magnus Ivarsson; Meredith J Noetzel; J Scott Daniels; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn; Carrie K Jones
Journal:  Neuropharmacology       Date:  2015-11-23       Impact factor: 5.250

9.  Dopamine modulates the responsivity of mediodorsal thalamic cells recorded in vitro.

Authors:  A Lavin; A A Grace
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 10.  Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.

Authors:  Stefan Cohrs
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.